Literature DB >> 22801653

New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease.

Eva Denise Martin1, Gian Felice De Nicola, Michael S Marber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22801653     DOI： 10.1161/CIRCULATIONAHA.111.071886

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  34 in total

1.  Disruption of TAB1/p38α interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury.

Authors:  Qingyang Wang; Jiannan Feng; Jing Wang; Xueying Zhang; Dalin Zhang; Ting Zhu; Wendie Wang; Xiaoqian Wang; Jianfeng Jin; Junxia Cao; Xinying Li; Hui Peng; Yan Li; Beifen Shen; Jiyan Zhang
Journal:  Mol Ther       Date:  2013-07-23       Impact factor: 11.454

2.  Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells.

Authors:  Rosa Bretón-Romero; Hermann Kalwa; Santiago Lamas; Thomas Michel
Journal:  Biochim Biophys Acta       Date:  2013-06-25

3.  Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.

Authors:  Daohong Chen; Chirayu P Goswami; Riesa M Burnett; Manjushree Anjanappa; Poornima Bhat-Nakshatri; William Muller; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2014-06-30       Impact factor: 12.701

4.  Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?

Authors:  Andrew R Kompa
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction?

Authors:  Matthias Dewenter; Michael Wagner; Ali El-Armouche
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Apoptosis Signal-regulating Kinase 1 (ASK1)-p38 Pathway-dependent Cytoplasmic Translocation of the Orphan Nuclear Receptor NR4A2 Is Required for Oxidative Stress-induced Necrosis.

Authors:  Takeshi Watanabe; Shiori Sekine; Isao Naguro; Yusuke Sekine; Hidenori Ichijo
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

Review 7.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

8.  p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart.

Authors:  Tomohiro Yokota; Jin Li; Jijun Huang; Zhaojun Xiong; Qing Zhang; Tracey Chan; Yichen Ding; Christoph Rau; Kevin Sung; Shuxun Ren; Rajan Kulkarni; Tzung Hsiai; Xinshu Xiao; Marlin Touma; Susumu Minamisawa; Yibin Wang
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced Neuroinflammation in BV2 Microglia and a Mouse Model.

Authors:  Min Sung Gee; Sang-Won Kim; Namkwon Kim; Soo Jin Lee; Myung Sook Oh; Hee Kyung Jin; Jae-Sung Bae; Kyung-Soo Inn; Nam-Jung Kim; Jong Kil Lee
Journal:  Neurochem Res       Date:  2018-10-16       Impact factor: 3.996

10.  Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.

Authors:  Xiu-Fang Gao; Yue Zhou; Da-Ying Wang; Kar-Sheng Lew; Arthur Mark Richards; Peipei Wang
Journal:  Mol Cell Biochem       Date:  2014-09-23       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.